Envision Healthcare (EVHC) Lowered to “Hold” at SunTrust Banks

Envision Healthcare (NYSE:EVHC) was downgraded by equities researchers at SunTrust Banks from a “buy” rating to a “hold” rating in a research note issued on Tuesday, The Fly reports.

EVHC has been the topic of a number of other research reports. ValuEngine cut Envision Healthcare from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 2nd. Robert W. Baird restated an “outperform” rating and issued a $50.00 price target (up previously from $45.00) on shares of Envision Healthcare in a research report on Wednesday, March 7th. Cantor Fitzgerald reiterated a “hold” rating and issued a $37.00 target price on shares of Envision Healthcare in a research report on Wednesday, February 21st. Zacks Investment Research cut Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, May 1st. Finally, Mizuho set a $38.00 target price on Envision Healthcare and gave the company a “hold” rating in a research report on Friday, March 2nd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $41.10.

Shares of NYSE EVHC opened at $44.60 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 2.25 and a debt-to-equity ratio of 0.65. Envision Healthcare has a 52 week low of $23.77 and a 52 week high of $64.00. The firm has a market capitalization of $5.29 billion, a P/E ratio of 17.98, a P/E/G ratio of 0.99 and a beta of 0.46.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.71 EPS for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.07. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The company had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.02 billion. During the same quarter last year, the business earned $0.77 earnings per share. Envision Healthcare’s revenue was up 10.6% on a year-over-year basis. equities analysts anticipate that Envision Healthcare will post 3.39 EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. Maverick Capital Ltd. boosted its stake in shares of Envision Healthcare by 30.7% during the fourth quarter. Maverick Capital Ltd. now owns 10,002,182 shares of the company’s stock valued at $345,675,000 after purchasing an additional 2,349,648 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Envision Healthcare by 6.5% during the fourth quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock valued at $277,462,000 after purchasing an additional 487,314 shares in the last quarter. Roystone Capital Management LP boosted its stake in shares of Envision Healthcare by 88.8% during the first quarter. Roystone Capital Management LP now owns 2,123,300 shares of the company’s stock valued at $81,598,000 after purchasing an additional 998,500 shares in the last quarter. Guggenheim Capital LLC boosted its stake in shares of Envision Healthcare by 140.4% during the fourth quarter. Guggenheim Capital LLC now owns 1,979,973 shares of the company’s stock valued at $68,429,000 after purchasing an additional 1,156,381 shares in the last quarter. Finally, Neuberger Berman Group LLC boosted its stake in shares of Envision Healthcare by 16.3% during the first quarter. Neuberger Berman Group LLC now owns 1,771,362 shares of the company’s stock valued at $68,074,000 after purchasing an additional 247,802 shares in the last quarter.

Envision Healthcare Company Profile

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

The Fly

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply